Grants and Contributions

Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.

As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision and the SPOR Patient Engagement Framework. Categories are described in the Funds Available section.

Applications must ensure relevance to all objectives:
• To enable a comprehensive and timely understanding of the biological, clinical, social, and population health implications of emerging SARS-CoV-2 VOCs and their relevance for public health, health systems and policy through the establishment of an interdisciplinary CIHR Network for Emerging Variants Research;
• To provide an integrated platform within Canada to coordinate across different research areas that focus on emerging VOCs research through coordination across different disciplines and pillars of research and integrating surveillance efforts through a sustained collaboration/partnership with the VOCN and other relevant local, national, and international partners; and
• To swiftly provide high-quality and real-time data on urgent and emerging research priorities in support of Canada rapid response to emerging SARS-COV2 variants, through building and activating as needed, a rapid response capacity in Canada which can coordinate and conduct all aspects of VOC related research.

The objectives of Stream 1 are:
•Accelerate rapid research on SARS-CoV-2 variants in Canada to contribute to the national and global efforts to address SARS-CoV-2 variants; and
•Generate timely evidence on SARS-CoV-2 variants that will show impact within 3-6 months and is relevant to biological, clinical, health system, and public health strategies.

Stream 1 applicants are strongly encouraged to consider maximizing impact by outlining how they intend to participate in:
1.The formation of a network (Stream 2) or participating in a network formed by another NPA (Stream 2); and,
2.The CIHR Network for Emerging Variants Research once established.

The objective is to invest in targeted COVID priority research areas from the Fall 2020 Project Grant competition such as vaccine hesitancy, pregnant women and children, racialized populations, Indigenous, confidence in science and SARS-CoV-2 variants.

• The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide funding for applications in which the objectives and aims are determined to be largely and directly relevant to the INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

• The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide funding for applications in which the objectives and aims are determined to be largely and directly relevant to the INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

The objective is to invest in targeted COVID priority research areas from the Fall 2020 Project Grant competition such as vaccine hesitancy, pregnant women and children, racialized populations, Indigenous, confidence in science and SARS-CoV-2 variants.

• This prize was established to honour the past Scientific Director of the Institute of Aging, Yves Joanette, for his outstanding contributions to the area of research on aging in Canada and internationally.
• This prize will be given annually to the highest ranking funded project in the Project Grant competition that is relevant to one of the Institute of Aging’s Strategic Directions as described below:
•
o Strategic Direction 1: Health and Wellness over the Trajectory of Aging
Priority Areas:
¿ Life trajectory as a determinant of healthy and satisfying aging
¿ Added life to the later years
o Strategic Direction 2: Facing the Complex Health Challenges of an Older Population
Priority Areas:
¿ Understanding, preventing and addressing multiple chronic conditions
¿ Facing the challenge of dementia
¿ Recognizing new emerging aging populations
¿ Ensuring the adaptation of healthcare and services to an aging population
¿ Informing late-life care and decisions

Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.

As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision and the SPOR Patient Engagement Framework. Categories are described in the Funds Available section.

• The CIHR HIV/AIDS Research Initiative (RI), managed by the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI (as identified in the Public Health Agency of Canada’s pan-Canadian STBBI framework for action). This includes, but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR Research Themes : biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations identified by Canada’s pan-Canadian STBBI framework for action is highly encouraged.
• Information on the strategic directions of the CIHR HIV/AIDS Research Initiative can be found in the CIHR HIV/AIDS Research Initiative: Strategic Plan (2015-2020).